Sunshine Biopharma (SBFM) Payables (2010 - 2026)
Sunshine Biopharma (SBFM) recorded Payables of $4.85 million in Q2 2026, up 1.1% from $4.8 million a year earlier but down 4.9% from the prior quarter.
Powered by 
Analysis
Sunshine Biopharma (SBFM) Payables (2010 - 2026) Analysis & Trends
At the end of FY2025, Sunshine Biopharma reported Payables of $5.66 million, up 2.2% from FY2024.
- Annual Payables has a five-year compound annual growth rate of 45.0% (FY2020 to FY2025).
- Across earlier years, Payables came in at $5.54 million in FY2024 (+114.4%), $2.59 million in FY2023 (-7.8%), $2.8 million in FY2022 and $42,942 in FY2021 (-95.1%).
- Quarterly Payables has ranged from $42,942 in Q4 2021 to $6.14 million in Q3 2025 over the past five years.
- On a year-over-year basis, Payables has increased for four consecutive quarters, with growth averaging 36.3% over the last eight quarters.
- Peak year-over-year performance for Payables in the last five years was growth of 362.5% in Q3 2023, against a decline of 95.1% in Q4 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $5.1 million (Q1 2026), $5.66 million (Q4 2025) and $6.14 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Sunshine Biopharma | 1.12 Mn | -37.97 Mn | 2.43 Mn | 4.85 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.85 Mn |
| Mar 31, 2026 | 5.10 Mn |
| Dec 31, 2025 | 5.66 Mn |
| Sep 30, 2025 | 6.14 Mn |
| Jun 30, 2025 | 4.80 Mn |
| Mar 31, 2025 | 5.02 Mn |
| Dec 31, 2024 | 5.54 Mn |
| Sep 30, 2024 | 4.16 Mn |
| Jun 30, 2024 | 4.93 Mn |
| Mar 31, 2024 | 3.62 Mn |
| Dec 31, 2023 | 2.59 Mn |
| Sep 30, 2023 | 2.22 Mn |
| Jun 30, 2023 | 1.76 Mn |
| Mar 31, 2023 | 2.74 Mn |
| Dec 31, 2022 | 2.80 Mn |
| Sep 30, 2022 | 480,209.00 |
| Jun 30, 2022 | 104,684.00 |
| Mar 31, 2022 | 95,234.00 |
| Dec 31, 2021 | 42,942.00 |
| Sep 30, 2021 | 386,687.00 |
API Access
Sunshine Biopharma Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=SBFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "SBFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=SBFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();